Friday, July 10, 2026

pharma · Not applicable, healthy volunteers · ulcerative pyoderma gangrenosum

InflaRx

InflaRx is a pharma organization headquartered in Jena, DE. Primary therapeutic focus areas include Not applicable, healthy volunteers, ulcerative pyoderma gangrenosum. NovaPharmaNews links 4 clinical program(s), 0 drug

Jena, DE HQ
2007 Founded
52 Employees
EMA registrant Type
Company details
Status
Public
HQ
Jena, DE
Founded
2007
Employees
52
Programs
4
Drugs
20
Patents
0
Clinical program

INF904-P1.2

Phase 1 · other · Not applicable, healthy volunteers

INF904-P1.2 for Not applicable, healthy volunteers is a Phase 1 program (other) at InflaRx GmbH with 1 ClinicalTrials.gov record(s).

← All InflaRx GmbH projects Phase 1 other active

Internal code INF904-P1.2

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
InflaRx GmbH
Phase
Phase 1
Modality
other
Indication
Not applicable, healthy volunteers
Status
active
Trials
1

Clinical trials